<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is an <z:e sem="disease" ids="C0277550" disease_type="Disease or Syndrome" abbrv="">endemic disease</z:e> in the western world </plain></SENT>
<SENT sid="1" pm="."><plain>Search for molecular signatures present in <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> that predict <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">tumor metastasis</z:e> potential has been proposed and in particular, a 17-gene molecular signature is associated with poor survival in <z:hpo ids='HP_0003002'>breast cancer</z:hpo>, <z:hpo ids='HP_0012125'>prostate cancer</z:hpo>, meduloblastoma and <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in a recent study </plain></SENT>
<SENT sid="2" pm="."><plain>Using quantitative real-time PCR assay (qPCR), our study observed <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-<z:mpath ids='MPATH_458'>normal</z:mpath> differential <z:chebi fb="40" ids="33697">RNA</z:chebi> expression in 15 of these 17 genes in a cohort of 52 stage III <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients (<z:hpo ids='HP_0000001'>all</z:hpo> p&lt;0.05), which signified the importance of these 17 signature genes in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Although no significant correlation was found between <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:chebi fb="40" ids="33697">RNA</z:chebi> levels of these 17 genes and some of clinical features (age, gender, and location, <z:hpo ids='HP_0000001'>all</z:hpo> p&gt;0.05), two distinct groups among these genes were observed with Spearman correlation scores&gt;0.6 (p&lt;0.01), suggesting co-expression/interaction within these genes </plain></SENT>
<SENT sid="4" pm="."><plain>Of the 37 patients for whom complete follow-up data was available, 12 patients had recurrence and 25 had no recurrence </plain></SENT>
<SENT sid="5" pm="."><plain>There was no significant difference in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:chebi fb="40" ids="33697">RNA</z:chebi> levels between recurrence and non-recurrence groups for the 17 genes (<z:hpo ids='HP_0000001'>all</z:hpo> p&gt;0.05), but the recurrence group had more patients with <z:e sem="disease" ids="C1334811" disease_type="Neoplastic Process" abbrv="">mucinous tumors</z:e> (9/12 vs. 7/25, p&lt;0.05) and more lymph node involvement (median 7.2 vs. 2.5, p&lt;0.05) compared to the non-recurrence group </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, survival analysis revealed a significant difference in patient overall survival time between low and high <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:chebi fb="40" ids="33697">RNA</z:chebi> levels for 1 of the 17 genes (PTTG1, p=0.024) </plain></SENT>
<SENT sid="7" pm="."><plain>Our qPCR validation study confirms the importance of most 17-gene molecular signature genes with differential <z:chebi fb="40" ids="33697">RNA</z:chebi> expression and suggests the relevance of PTTG1 for survival in <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
</text></document>